Publications: Mr Wayne Huttly
Vale SH, Huttly WJ, Wald NJ
(
2021
)
.
Antenatal screening for Down's syndrome: Revised nuchal translucency upper truncation limit due to improved precision of measurement
.
J Med Screen
vol.
28
,
(
2
)
88
-
92
.
Wald NJ, Bestwick JP, Lau KW, Huttly WJ, Ke W, Cheng R, Old RW
(
2019
)
.
A simple method to allow for guanine-cytosine amplification error in prenatal DNA screening for trisomy 18
.
Clinica Chimica Acta
vol.
496
,
13
-
17
.
Wald NJ, Bestwick JP, Huttly WJ, Aldis J, Borrell A, Goodburn S, Mills I
(
2019
)
.
Corrigendum to: Prenatal screening for Down syndrome in twin pregnancies: Estimates of screening performance based on 61 affected and 7302 unaffected twin pregnancies (Prenatal Diagnosis, (2018), 38, 13, (1079-1085), 10.1002/pd.5381)
.
Prenatal Diagnosis
vol.
39
,
(
6
)
489
-
491
.
WALD NJ, BESTWICK J, HUTTLY W, Aldis J, Borrell A, Goodburn S, Mills I
(
2018
)
.
Prenatal screening for Down syndrome in twin pregnancies: Estimates of screening performance based on 61 affected and 7302 unaffected twin pregnancies
.
Prenatal Diagnosis
WALD NJ, LAU KW, BESTWICK J, Old R, HUTTLY W, CHENG R
(
2018
)
.
Specifying a Gold-Standard for the validation of fetal fraction estimation in prenatal screening
.
Clinical Chemistry
vol.
64
,
(
9
)
1394
-
1399
.
BESTWICK JP, HUTTLY W, WALD N
(
2018
)
.
Serum marker truncation limits in first trimester antenatal screening for trisomy 18
.
Journal of Medical Screening
Wald NJ, Huttly WJ, Bestwick JP, Old R, Morris JK, Cheng R, Aquilina J, Peregrine E et al.
(
2018
)
.
Response to Walker
.
Genet Med
WALD NJ, Huttly WJ, Bestwick JP, Old R, Morris JK, Cheng R, Aquilina J, Peregrine E et al.
(
2017
)
.
Prenatal reflex DNA screening for trisomy 21, 18, and 13
.
Genetics in Medicine
Bestwick JP, Huttly WJ, Wald NJ
(
2017
)
.
Pregnancy-associated plasma protein-A truncation limits in antenatal screening for trisomy 18
.
J Med Screen969141316688499
-
969141316688499
.
Huttly WJ, Bestwick JP, Wald NJ
(
2016
)
.
Insulin dependent diabetes mellitus (IDDM) and first trimester markers in prenatal screening for Down syndrome
.
Prenatal Diagnosis
vol.
36
,
(
2
)
192
-
193
.
Wald NJ, Huttly WJ, Bestwick JP, Aquilina J, Peregrine E
(
2015
)
.
Reflex antenatal DNA screening for Down syndrome
.
Prenatal Diagnosis
vol.
35
,
(
11
)
1154
-
1154
.
(
2015
)
.
Corrigendum
.
J Med Screen
vol.
22
,
(
1
)
52
-
54
.
Bestwick JP, Huttly WJ, Wald NJ
(
2014
)
.
The estimation of median nuchal translucency values between 10 and 14 weeks of pregnancy
.
J Med Screen
vol.
21
,
(
2
)
110
-
112
.
Huttly W, Bestwick J, Wald N
(
2014
)
.
Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome
.
Prenat Diagn
vol.
34
,
(
4
)
406
-
407
.
Bestwick JP, Huttly WJ, Morris JK, Wald NJ
(
2014
)
.
Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women
.
PLoS One
vol.
9
,
(
2
)
Bestwick JP, Huttly WJ, Wald NJ
(
2013
)
.
Detection of trisomy 18 and trisomy 13 using first and second trimester Down's syndrome screening markers
.
J Med Screen
vol.
20
,
(
2
)
57
-
65
.
Bestwick JP, Huttly WJ, Wald NJ
(
2013
)
.
Allowing for ethnic group in antenatal screening for Down's syndrome
.
J Med Screen
vol.
20
,
(
1
)
52
-
54
.
Wald NJ, Bestwick JP, Huttly WJ
(
2013
)
.
Improvements in antenatal screening for Down's syndrome
.
J Med Screen
vol.
20
,
(
1
)
7
-
14
.
Bestwick JP, Huttly WJ, Wald NJ
(
2013
)
.
Allowing for ethnic group in antenatal screening for Down's syndrome
.
JOURNAL OF MEDICAL SCREENING
vol.
20
,
(
1
)
52
-
54
.
Huttly WJ, Wald NJ
(
2012
)
.
The estimation of gestational age of pregnancy for use in screening for Down syndrome using ultrasound measurements and embryo transfer date
.
Prenat Diagn
vol.
32
,
(
10
)
1008
-
1009
.
Wald NJ, Bestwick JP, Huttly WJ
(
2012
)
.
Effect of interrupting prenatal Down syndrome screening due to a large nuchal translucency
.
Prenat Diagn
vol.
32
,
(
7
)
655
-
661
.
Bestwick JP, Huttly WJ, Wald NJ
(
2012
)
.
Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome
.
Prenatal Diagnosis
vol.
32
,
(
7
)
Bestwick JP, Huttly WJ, Wald NJ
(
2012
)
.
Unconjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome
.
Prenat Diagn
vol.
32
,
(
3
)
299
-
301
.
Wald NJ, Bestwick JP, George LM, Huttly WJ
(
2012
)
.
Antenatal screening for Down syndrome using serum placental growth factor with the combined, quadruple, serum integrated and integrated tests
.
PLoS One
vol.
7
,
(
10
)
Huttly WJ, Wald NJ
(
2011
)
.
An audit of the detection of trisomy 18 in prenatal screening for Down syndrome using the Combined test
.
Prenat Diagn
vol.
31
,
(
13
)
Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles DM, Pandya P, David AL
(
2011
)
.
Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening
.
Ultrasound Obstet Gynecol
vol.
37
,
(
5
)
520
-
527
.
Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles D, Pandya P, David A
(
2010
)
.
Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of feto-placental proteins used for Down's syndrome screening
.
Ultrasound Obstet Gynecol
Bestwick JP, Huttly WJ, Wald NJ
(
2010
)
.
Distribution of nuchal translucency in antenatal screening for Down's syndrome (vol 17, pg 8, 2010)
.
J MED SCREEN
vol.
17
,
(
2
)
106
-
106
.
Bestwick JP, Huttly WJ, Wald NJ
(
2010
)
.
Distribution of nuchal translucency in antenatal screening for Down's syndrome
.
J Med Screen
vol.
17
,
(
1
)
8
-
12
.
Bestwick JP, Huttly WJ, Wald NJ
(
2010
)
.
Evaluation of a proposed mixture model to specify the distributions of nuchal translucency measurements in antenatal screening for Down's syndrome
.
J Med Screen
vol.
17
,
(
1
)
13
-
18
.
Wald NJ, Huttly WJ, Murphy KW, Ali K, Bestwick JP, Rodeck CH
(
2009
)
.
Antenatal screening for Down's syndrome using the Integrated test at two London hospitals
.
J Med Screen
vol.
16
,
(
1
)
7
-
10
.
Wald NJ, Huttly WJ, Bestwick JP
(
2008
)
.
Inhibin-A concentrations between 14 and 22 weeks of gestation
.
Prenat Diagn
vol.
28
,
(
4
)
360
-
361
.
Bestwick JP, Huttly WJ, Wald NJ
(
2008
)
.
First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency
.
J Med Screen
vol.
15
,
(
4
)
204
-
206
.
Weisz B, Pandya PP, David AL, Huttly W, Jones P, Rodeck CH
(
2007
)
.
Ultrasound findings after screening for Down syndrome using the integrated test
.
Obstet Gynecol
vol.
109
,
(
5
)
1046
-
1052
.
Weisz B, Pandya P, Chitty L, Jones P, Huttly W, Rodeck C
(
2007
)
.
Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice
.
BJOG
vol.
114
,
(
4
)
493
-
497
.
Huttly WJ, Morris JK, Bestwick JP, Wald NJ, Murphy K, Pandya PP
(
2006
)
.
Three stage contingent screening for Down syndrome
.
Prenat Diagn
vol.
26
,
(
12
)
Wald NJ, Barnes IM, Birger R, Huttly W
(
2006
)
.
Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy (vol 26, pg 539, 2006)
.
PRENATAL DIAGNOSIS
vol.
26
,
(
6
)
589
-
589
.
Wald NJ, Barnes IM, Birger R, Huttly W
(
2006
)
.
Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy
.
Prenat Diagn
vol.
26
,
(
6
)
539
-
544
.
Wald NJ, Bestwick JP, Huttly WJ, Morris JK, George LM
(
2006
)
.
Validation plots in antenatal screening for Down's syndrome
.
J Med Screen
vol.
13
,
(
4
)
166
-
171
.
Wald NJ, Huttly WJ, Rudnicka AR
(
2004
)
.
Recurrent false-positives in AFP screening for open neural tube defects
.
Prenat Diagn
vol.
24
,
(
12
)
1018
-
1019
.
Huttly W, Rudnicka A, Wald NJ
(
2004
)
.
Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus
.
Prenat Diagn
vol.
24
,
(
10
)
804
-
807
.
RUDNICKA AR, Wald NJ, Huttly WJ
(
2004
)
.
Parental screening for Downs syndrome: the problem of recurrent false-positives
.
Prenatal Diagnosis.
vol.
24
,
389
-
392
.
Rudnicka AR, WALD NJ, Huttly W
(
2004
)
.
Prenatal screening for Down syndrome: the problem of recurrent false-positives
.
Prenatal Diagnosis.
vol.
24
,
(
5
)
389
-
392
.
Alberman E, Huttly W, Hennessy E, McIntosh A
(
2003
)
.
The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome
.
Prenat Diagn
vol.
23
,
(
10
)
801
-
806
.
Wald NJ, Huttly WJ, Hackshaw AK
(
2003
)
.
Antenatal screening for Down's syndrome with the quadruple test
.
Lancet
vol.
361
,
(
9360
)
835
-
836
.
Wald NJ, Huttly W, Hackshaw AK, Christiansen M, Larsen SO, Nørgaard-Pedersen B, Howe D, Wellesley D
(
2002
)
.
Antenatal screening policies for Down's syndrome [3] (multiple letters)
.
British Medical Journal
vol.
325
,
(
7371
)
1034
-
1035
.
Wald NJ, Huttly W, Hackshaw AK
(
2002
)
.
Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid
.
BMJ
vol.
325
,
(
7371
)
Rudnicka AR, Wald NJ, Huttly W, Hackshaw AK
(
2002
)
.
Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance
.
Prenat Diagn
vol.
22
,
(
10
)
893
-
897
.